CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Endo Pharmaceuticals Inc. v. Sandoz Inc.

1:14-cv-01388

Overview

Case Number 1:14-cv-01388
Filing Date 2014-11-07
Status Terminated
Termination Date 2015-07-02
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Sandoz Inc. Operating Company

Represented By

1 Attorneys Listed

Dominick T. Gattuso

Heyman Enerio Gattuso & Hirzel LLP

Tel: +1 (302) 472-7311
Fax: +1 (302) 472-7301

300 Delaware Avenue, Suite 200, Wilmington, DE 19801

Plaintiff

Mallinckrodt LLC Operating Company

Represented By

2 Attorneys Listed

Julia Heaney

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Endo Pharmaceuticals Inc. Operating Company

Represented By

2 Attorneys Listed

Julia Heaney

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 7 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (7 found):
U.S. Courts: 7
U.S. District Court 2014-11-07
1:14-cv-01383

Endo Pharmaceuticals Inc. v. Impax Laboratories Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-11-07
1:14-cv-01387

Endo Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Limited

Asserted Patent
Status: DED
U.S. District Court 2014-11-07
1:14-cv-01382

Endo Pharmaceuticals Inc. v. Amneal Pharmaceuticals LLC

Asserted Patent
Status: DED
U.S. District Court 2014-11-07
1:14-cv-01385

Endo Pharmaceuticals Inc. v. Par Pharmaceutical Companies Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-11-07
1:14-cv-01389

Endo Pharmaceuticals Inc. v. Teva Pharmaceuticals USA Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-11-07
1:14-cv-01384

Endo Pharmaceuticals Inc. v. Impax Laboratories Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-11-07
1:14-cv-01381

Endo Pharmaceuticals Inc. v. Actavis LLC

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8808737
Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment
Filed: 2010-03-03
Issued: 2014-08-19
Active (3.3 yrs remaining)
Expires: 2030-03-03
US8871779
Process for preparing morphinan-6-one products with low levels of Ξ±,Ξ²-unsaturated ketone compounds
Filed: 2007-03-02
Issued: 2014-10-28
Active (3.0 yrs remaining) +996d PTA
Expires: 2029-11-22

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

8

Dispositive

0

Granted

0

Denied

0

Pending / Review

8

Motions by Category

Procedural / Extension Motion 8

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Defendant Sandoz Inc. to Move, Answer, or Otherwise Respond to the Complaint to June 12, 2015 - filed by Sandoz Inc.. (Gattuso, D...
Entry #17 • 2015-05-20 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Defendant Sandoz Inc. to Move, Answer or Otherwise Respond to the Complaint to May 20, 2015 - filed by Sandoz Inc.. (Gattuso, Dom...
Entry #16 • 2015-04-17 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Defendant Sandoz Inc. to Move, Answer, or Otherwise Respond to the Complaint to April 20, 2015 - filed by Sandoz Inc.. (Gattuso, ...
Entry #15 • 2015-03-20 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Defendant Sandoz Inc. to Respond to the Complaint to March 20, 2015 - filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 03/06/2...
Entry #14 • 2015-03-06 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Defendant Sandoz Inc. to Move, Answer or Otherwise Respond to the Complaint to March 6, 2015 - filed by Sandoz Inc.. (Gattuso, Do...
Entry #13 • 2015-02-19 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Defendants to Move, Answer, or Otherwise Respond to the Complaint to February 20, 2015 - filed by Sandoz Inc.. (Gattuso, Dominick...
Entry #11 • 2015-01-20 Document →

Docket Entries

(20 total)
Pleading / Complaint

COMPLAINT - filed against Sandoz Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1622595.) - filed by Endo Phamaceuticals Inc.. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(rwc) (Entered: 11/10/2014)

Entry #1 • 2014-11-07
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) (Entered: 11/10/2014)

Entry #2 • 2014-11-07
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,808,737 B2; 8,871,779 B2. (rwc) Modified on 11/10/2014 (rwc). (Entered: 11/10/2014)

Entry #3 • 2014-11-07
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Endo International PLC for Endo Phamaceuticals Inc. filed by Endo Phamaceuticals Inc. (rwc) (Entered: 11/10/2014)

Entry #4 • 2014-11-07
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mallinckrodt plc, Other Affiliate Mallinckrodt Inc. for Mallinckrodt LLC filed by Mallinckrodt LLC. (rwc) (Entered: 11/10/2014)

Entry #5 • 2014-11-07
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc